All these molecules inhibit TRAP1 with a high selectivity over HSP90, abolishing TRAP1-dependent down-regulation of SDH activity in cancer cells and their in vitro tumorigenic growth (157, 158). This evidence concerns the gene TRAP1 and cancer.